The reporting of blinding in orthodontic randomized controlled trials: where do we stand?

Affiliations


Abstract

Objective: To analyse in 10 orthodontic journals how many randomized controlled trials (RCTs) performed 'single-', 'double-', 'triple-', or 'outcome assessors blinding' and to evaluate, from the number of RCTs that did not conduct blinding, how many could actually have achieved it.

Material and methods: Randomized controlled trials published in 10 orthodontic journals between 1 September 2012 and 28 February 2018 were included. A search was performed in PubMed and conducted for publication type 'randomized controlled trial' for each journal. Two reviewers independently analysed each RCT and registered that blinding was performed and included which specific type. It was also evaluated whether misclassifications of blinding items occurred and whether it was possible to achieve blinding among the RCTs that did not perform blinding.

Results: After applying the inclusion criteria, 203 RCTs were assessed, and 61.6 per cent of them had used blinding, with the main type being 'outcome assessors blinding' (40.4%) followed by 'single-blinding' (15.3%), 'double-blinding' (2.5%), and 'triple-blinding' (3.4%). In 38.4 per cent of the trials, no blinding was performed; however, 79.4 per cent of them could have achieved blinding. Fifteen RCTs (7.3%) misclassified the blinding in relation to single-, double-, or triple-blinding. Journals followed the CONSORT (AJODO, EJO, JO, OCR) published together significantly more RCTs that performed blinding than journals not following the CONSORT.

Conclusions: Blinding of outcome assessors was the most frequent type, as orthodontic trials are often of intervention design and thereby difficult to mask for patients and trial staff. The misclassifications of blinding items may indicate suboptimal knowledge among researchers and peer-reviewers regarding the definitions for diverse blinding types.


Similar articles

The reporting quality of randomized controlled trials in orthodontics.

Lempesi E, Koletsi D, Fleming PS, Pandis N.J Evid Based Dent Pract. 2014 Jun;14(2):46-52. doi: 10.1016/j.jebdp.2013.12.001. Epub 2014 Apr 18.PMID: 24913524

In the dark: the reporting of blinding status in randomized controlled trials.

Montori VM, Bhandari M, Devereaux PJ, Manns BJ, Ghali WA, Guyatt GH.J Clin Epidemiol. 2002 Aug;55(8):787-90. doi: 10.1016/s0895-4356(02)00446-8.PMID: 12384193

Definitions of blinding in randomised controlled trials of interventions published in high-impact anaesthesiology journals: a methodological study and survey of authors.

Penić A, Begić D, Balajić K, Kowalski M, Marušić A, Puljak L.BMJ Open. 2020 Apr 12;10(4):e035168. doi: 10.1136/bmjopen-2019-035168.PMID: 32284390 Free PMC article.

Hawthorne effect reporting in orthodontic randomized controlled trials: truth or myth? Blessing or curse?

Abdulraheem S, Bondemark L.Eur J Orthod. 2018 Sep 28;40(5):475-479. doi: 10.1093/ejo/cjx089.PMID: 29186392 Review.

Risk of bias and magnitude of effect in orthodontic randomized controlled trials: a meta-epidemiological review.

Koletsi D, Spineli LM, Lempesi E, Pandis N.Eur J Orthod. 2016 Jun;38(3):308-12. doi: 10.1093/ejo/cjv049. Epub 2015 Jul 14.PMID: 26174770 Free PMC article. Review.


Cited by

Who knew? The misleading specificity of "double-blind" and what to do about it.

Lang TA, Stroup DF.Trials. 2020 Aug 5;21(1):697. doi: 10.1186/s13063-020-04607-5.PMID: 32758278 Free PMC article.


KMEL References